anastrozole has been researched along with Atypical Endometrial Hyperplasia in 4 studies
Atypical Endometrial Hyperplasia: A benign form of endometrial hyperplasia with increased number of cells with atypia. The atypical cells are large and irregular and have an increased nuclear/cytoplasmic ratio. The risk of progression to endometrial carcinoma rises with the increasing degree of cell atypia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is a preliminary study investigating the efficacy of aromatase inhibitor anastrozole in treating endometrial hyperplasia in obese postmenopausal women." | 9.11 | Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women. ( Agorastos, T; Bontis, JN; Efstathiadis, E; Pantazis, K; Vaitsi, V; Vavilis, D, 2005) |
| "To investigate whether there may be a role for aromatase inhibitors (AIs) in the treatment of endometrial hyperplasia (EH) and endometrial adenocarcinoma (EA) in postmenopausal women, a retrospective study on the effect of aromatase inhibitors (anastrozole or letrozole) was conducted for 16 patients who were not amenable to surgical treatment." | 7.75 | Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma. ( Barker, LC; Brand, IR; Crawford, SM, 2009) |
| "Adjuvant therapy with anastrozole may be beneficial in resolving endometrial hyperplasia in patients with breast cancer." | 7.74 | Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report. ( Cooper, BC; Stilwill, SE, 2007) |
| "This is a preliminary study investigating the efficacy of aromatase inhibitor anastrozole in treating endometrial hyperplasia in obese postmenopausal women." | 5.11 | Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women. ( Agorastos, T; Bontis, JN; Efstathiadis, E; Pantazis, K; Vaitsi, V; Vavilis, D, 2005) |
| "To investigate whether there may be a role for aromatase inhibitors (AIs) in the treatment of endometrial hyperplasia (EH) and endometrial adenocarcinoma (EA) in postmenopausal women, a retrospective study on the effect of aromatase inhibitors (anastrozole or letrozole) was conducted for 16 patients who were not amenable to surgical treatment." | 3.75 | Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma. ( Barker, LC; Brand, IR; Crawford, SM, 2009) |
| "Adjuvant therapy with anastrozole may be beneficial in resolving endometrial hyperplasia in patients with breast cancer." | 3.74 | Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report. ( Cooper, BC; Stilwill, SE, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, LC | 1 |
| Brand, IR | 1 |
| Crawford, SM | 1 |
| Koloszar, S | 1 |
| Pal, Z | 1 |
| Kereszturi, A | 1 |
| Vajda, G | 1 |
| Pal, A | 1 |
| Daru, J | 1 |
| Agorastos, T | 1 |
| Vaitsi, V | 1 |
| Pantazis, K | 1 |
| Efstathiadis, E | 1 |
| Vavilis, D | 1 |
| Bontis, JN | 1 |
| Stilwill, SE | 1 |
| Cooper, BC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gonadotropin-releasing Hormone Agonist Combined With Letrozole Compared With Megestrol Acetate or Medroxyprogesterone Acetate Alone as Fertility-sparing Treatment in Early Endometrial Cancer[NCT05247268] | Phase 2 | 104 participants (Anticipated) | Interventional | 2022-03-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for anastrozole and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women.
Topics: Aged; Anastrozole; Aromatase Inhibitors; Body Mass Index; Endometrial Hyperplasia; Endometrium; Fema | 2005 |
3 other studies available for anastrozole and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma.
Topics: Aged; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Carcinoma; Disease Progression; Endo | 2009 |
Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity.
Topics: Administration, Oral; Aged; Anastrozole; Aromatase Inhibitors; Atrophy; Endometrial Hyperplasia; End | 2012 |
Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Endometrial Hyperplasia | 2007 |